| Followers | 200 |
| Posts | 25574 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Tuesday, July 28, 2020 10:34:35 AM
However, that was not what I was debating. The issue was alleged that microcaps are a means for universities and doctors to scam basically, as if that is basically just what they are for... and this is not a factual allegation even if one were to point to individual cases, it simply is not factual.
It’s more along the order of false information or disinfo that jumps to a conclusion and feeds someone’s predisposition to believe such an idea. Maybe because they actually did invest in a bad idea that failed or even, possibly a particular fraud. But the broad characterization is only true for those who basically do not know what they are doing and are attracted to frauds, maybe because they are looking to get rich quick and have no means to do due diligence, and that happens with any range of companies and even to people presumed to be sophisticated.
We have the one case of that testing company to keep in mind that fooled all of Silicon Valley, but it ironically has nothing to do with doctors or universities. The founder had not even graduated from college and had a very poor explanation of the science, and in fact got by by saying it was all too secret.
But those cases are rare and do not typically involve real FDA trials and real/major universities. No doubt there are cases, but it is not the norm. Not even a moderately sized minority of the companies, let alone the majority.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
